Minerva Neurosciences (NERV) Tops Q2 EPS by 47c

Minerva Neurosciences (NASDAQ: NERV) reported Q2 EPS of ($0.43), $0.47 better than the analyst estimate of ($0.90).

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Trifecta Gold closes $1.66M private placement for Yukon exploration
• Morgan Stanley Upgrades Galp Energia SGPS SA (GALP:LI) (GLPEF) to Overweight